YOUR FRIENDS' ACTIVITY

    Diseases/Conditions News Headlines

    • AMA calls obesity a disease Paul Sisson - @ The San Diego Union-Tribune - 1 hr 45 mins ago

      Decision came after debate among doctors in Chicago. More »AMA calls obesity a disease

      Decision came after debate among doctors in Chicago.

    • Prostate cancer treatment tied to hernia risk Kerry Grens - Reuters - 9 hrs ago

      By Kerry Grens NEW YORK (Reuters Health) - Prostate removal or radiation therapy to treat cancer is tied to two- to four-fold higher than usual risk of later having a … More »Prostate cancer treatment tied to hernia risk

      By Kerry Grens NEW YORK (Reuters Health) - Prostate removal or radiation therapy to treat cancer is tied to two- to four-fold higher than usual risk of later having a hernia repaired, according to a new study. It's not clear why hernia repairs are more common among these men. There might be tissue damage caused by the cancer …

    • Viewpoint: Defining Obesity as a Disease May Do More Harm Than Good Maia Szalavitz - Time.com - 9 hrs ago

      The label is supposed to improve awareness and treatments for the condition, but similar proclamations about alcoholism and other addictions haven’t been so successful. … More »Viewpoint: Defining Obesity as a Disease May Do More Harm Than Good

      The label is supposed to improve awareness and treatments for the condition, but similar proclamations about alcoholism and other addictions haven’t been so successful.

    • An overweight woman sits on a chair in Times Square in New York
      U.S. doctor group votes to recognize obesity as a disease Nick Carey - Reuters - 10 hrs ago

      By Nick Carey CHICAGO (Reuters) - In order to fight what it described as an "obesity epidemic," the American Medical Association voted on Tuesday to recognize obesity … More »U.S. doctor group votes to recognize obesity as a disease

      An overweight woman sits on a chair in Times Square in New York

      By Nick Carey CHICAGO (Reuters) - In order to fight what it described as an "obesity epidemic," the American Medical Association voted on Tuesday to recognize obesity as a disease and recommended a number of measures to fight it. The association voted on the measure at its annual meeting in Chicago. The AMA noted that obesity …

    • Cervical cancer vaccines cut rates of HPV infections: U.S Reuters - 11 hrs ago

      CHICAGO (Reuters) - The U.S. introduction of a vaccine to prevent cervical cancer in 2006 has reduced infections with the human papillomavirus or HPV - the sexually transmitted … More »Cervical cancer vaccines cut rates of HPV infections: U.S

      CHICAGO (Reuters) - The U.S. introduction of a vaccine to prevent cervical cancer in 2006 has reduced infections with the human papillomavirus or HPV - the sexually transmitted virus that causes the disease - by more than half among girls and young women, U.S. health officials said on Wednesday. The results were better …

    • AstraZeneca, Bristol diabetes drug disappoints in key test Ben Hirschler - Reuters - 21 hrs ago

      By Ben Hirschler LONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing … More »AstraZeneca, Bristol diabetes drug disappoints in key test

      By Ben Hirschler LONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might demonstrate an edge over rivals. The companies, which jointly sell several diabetes drugs, said on Wednesday the so-called …

    • U.S. court finds Novo Nordisk Prandin diabetes drug patent invalid Reuters - Tue, Jun 18, 2013

      (Reuters) - A U.S. appeals court found the patent on Novo Nordisk's Prandin diabetes drug in combination with metformin to be invalid, paving the way for introduction … More »U.S. court finds Novo Nordisk Prandin diabetes drug patent invalid

      (Reuters) - A U.S. appeals court found the patent on Novo Nordisk's Prandin diabetes drug in combination with metformin to be invalid, paving the way for introduction of a generic version of the medicine, the Danish drugmaker said on Tuesday. In a 2-1 ruling, the U.S. Court of Appeals affirmed a district court ruling handed …

    • New Virus Delivery Method Could Help Treat Blinding Diseases Vonda J. Sines - Yahoo! Contributor Network - Tue, Jun 18, 2013

      Researchers have developed an easier method to insert viruses carrying special genes into the eye. Their eventual goal is restoring sight destroyed by blinding disea … More »New Virus Delivery Method Could Help Treat Blinding Diseases

      Researchers have developed an easier method to insert viruses carrying special genes into the eye. Their eventual goal is restoring sight destroyed by blinding diseases.

    • Adding Red Meat to Your Diet Linked to Higher Risk of Type 2 Diabetes Alexandra Sifferlin - Time.com - Tue, Jun 18, 2013

      Loading up on burgers and deli meats may be tempting, but too much red meat could trigger metabolic changes that upset the body’s glucose balance. More »Adding Red Meat to Your Diet Linked to Higher Risk of Type 2 Diabetes

      Loading up on burgers and deli meats may be tempting, but too much red meat could trigger metabolic changes that upset the body’s glucose balance.

    • 'Night Stalker' killer Richard Ramirez died of cancer Reuters - Mon, Jun 17, 2013

      LOS ANGELES (Reuters) - The California serial killer known as the "Night Stalker," who died this month at age 53 while on death row for a mid-1980s reign of terror in … More »'Night Stalker' killer Richard Ramirez died of cancer

      LOS ANGELES (Reuters) - The California serial killer known as the "Night Stalker," who died this month at age 53 while on death row for a mid-1980s reign of terror in the Los Angeles area, succumbed to complications of cancer, authorities said. Richard Ramirez, who in 1989 was convicted of committing 13 murders in the Los …

    • In this undated photo provided by Susan G. Komen for the Cure, new President and CEO Judith A. Salerno, left, is shown with Komen Founder and now Chair of Global Strategy Nancy G. Brinker. The breast cancer charity on Monday, June 17, 2013, announced that it named Salerno as its new leader. Salerno replaces Brinker, the charity's founder, who announced last summer she would step down, following an onslaught of criticism over Komen's decision to stop funding Planned Parenthood.  (AP Photo/Susan G. Koman for the Cure)
      Komen breast cancer charity names new CEO JAMIE STENGLE - AP - Mon, Jun 17, 2013

      DALLAS (AP) — Susan G. Komen for the Cure announced Monday that a physician with a long career in health policy and research will become the breast cancer charity's new … More »Komen breast cancer charity names new CEO

      In this undated photo provided by Susan G. Komen for the Cure, new President and CEO Judith A. Salerno, left, is shown with Komen Founder and now Chair of Global Strategy Nancy G. Brinker. The breast cancer charity on Monday, June 17, 2013, announced that it named Salerno as its new leader. Salerno replaces Brinker, the charity's founder, who announced last summer she would step down, following an onslaught of criticism over Komen's decision to stop funding Planned Parenthood.  (AP Photo/Susan G. Koman for the Cure)

      DALLAS (AP) — Susan G. Komen for the Cure announced Monday that a physician with a long career in health policy and research will become the breast cancer charity's new president and CEO.

    • J&J in $1 billion deal to bolster prostate-cancer focus Ransdell Pierson - Reuters - Mon, Jun 17, 2013

      By Ransdell Pierson (Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster … More »J&J in $1 billion deal to bolster prostate-cancer focus

      By Ransdell Pierson (Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired another experimental prostate-cancer treatment four years ago that has become a leading brand. J&J on Monday …

    • Wait-and-see may be best for early prostate cancer Genevra Pittman - Reuters - Mon, Jun 17, 2013

      By Genevra Pittman NEW YORK (Reuters Health) - Watching and routinely examining men with early, slow-growing prostate cancer is more effective and cheaper than sending … More »Wait-and-see may be best for early prostate cancer

      By Genevra Pittman NEW YORK (Reuters Health) - Watching and routinely examining men with early, slow-growing prostate cancer is more effective and cheaper than sending them to surgery or radiation right away, according to a new study. The findings are based on a model of 65- to 75-year-old men that takes into account costs …

    • Eating more red meat tied to higher diabetes risk Andrew M. Seaman - Reuters - Mon, Jun 17, 2013

      By Andrew M. Seaman NEW YORK (Reuters Health) - Increasing the number of hamburgers and other red meat people eat on a daily basis is linked to a higher risk of developing … More »Eating more red meat tied to higher diabetes risk

      By Andrew M. Seaman NEW YORK (Reuters Health) - Increasing the number of hamburgers and other red meat people eat on a daily basis is linked to a higher risk of developing diabetes down the road, according to a new study. "I think the difference is enough to encourage people at least not to increase red meat consumption, …

    • Roche drug approved in Japan for treatment of brain cancer Reuters - Mon, Jun 17, 2013

      ZURICH (Reuters) - Japan's health ministry has approved drug Avastin for the treatment of aggressive brain cancer in Japan, Swiss pharmaceuticals company Roche said on … More »Roche drug approved in Japan for treatment of brain cancer

      ZURICH (Reuters) - Japan's health ministry has approved drug Avastin for the treatment of aggressive brain cancer in Japan, Swiss pharmaceuticals company Roche said on Monday. Avastin is the first new medicine approved worldwide for newly diagnosed glioblastoma, the most common and aggressive form of primary brain cancer, …

    • Scientists Develop New Mouse Model to Study Crohn's Disease Vonda J. Sines - Yahoo! Contributor Network - Fri, Jun 14, 2013

      Researchers at Canada's McMaster University have taken an alternative path in trying to uncover more information about Crohn's disease. They have developed a new mouse … More »Scientists Develop New Mouse Model to Study Crohn's Disease

      Researchers at Canada's McMaster University have taken an alternative path in trying to uncover more information about Crohn's disease. They have developed a new mouse model to study the digestive disorder.

    • FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman’s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)
      Court ruling may open up breast cancer gene tests MARILYNN MARCHIONE - AP - Thu, Jun 13, 2013

      A ruling by the Supreme Court that human genes can't be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the … More »Court ruling may open up breast cancer gene tests

      FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman’s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)

      A ruling by the Supreme Court that human genes can't be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.

    • AstraZeneca taps outside experts to screen cancer compounds Reuters - Thu, Jun 13, 2013

      LONDON (Reuters) - British drugmaker AstraZeneca is deepening its collaboration with academia by roping in more outside researchers to help to find new cancer drugs. … More »AstraZeneca taps outside experts to screen cancer compounds

      LONDON (Reuters) - British drugmaker AstraZeneca is deepening its collaboration with academia by roping in more outside researchers to help to find new cancer drugs. Scientists at the Cancer Research UK Paterson Institute for Cancer Research at the University of Manchester will use the company's compounds as a starting …

    • Lilly halts Alzheimer's drug trial due to liver problems Ransdell Pierson - Reuters - Thu, Jun 13, 2013

      By Ransdell Pierson (Reuters) - Eli Lilly and Co. said on Thursday it halted a mid-stage study of an experimental Alzheimer's disease treatment due to potential liver … More »Lilly halts Alzheimer's drug trial due to liver problems

      By Ransdell Pierson (Reuters) - Eli Lilly and Co. said on Thursday it halted a mid-stage study of an experimental Alzheimer's disease treatment due to potential liver toxicity, the latest setback in the quest to find a treatment that can slow or cure the memory-robbing condition. Lilly said the Phase II study of the drug, …

    • Lilly stops mid-stage Alzheimer's drug study AP - Thu, Jun 13, 2013

      NEW YORK (AP) — Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects … More »Lilly stops mid-stage Alzheimer's drug study

      NEW YORK (AP) — Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.

    • A Persistent Case of Diabetes Mellitus in Guam
      A Persistent Case of Diabetes Mellitus in Guam Jim Haw - Scientific American - Thu, Jun 13, 2013

      A Persistent Case of Diabetes Mellitus in Guam More »A Persistent Case of Diabetes Mellitus in Guam

      A Persistent Case of Diabetes Mellitus in Guam

      A Persistent Case of Diabetes Mellitus in Guam

    • Scientists Design Breath Sensor Device to Detect and Monitor Diabetes Vonda J. Sines - Yahoo! Contributor Network - Thu, Jun 13, 2013

      University of Pittsburgh chemists have come up with a breath sensor that's designed to detect and monitor diabetes. Although they have yet to test the prototype on humans, … More »Scientists Design Breath Sensor Device to Detect and Monitor Diabetes

      University of Pittsburgh chemists have come up with a breath sensor that's designed to detect and monitor diabetes. Although they have yet to test the prototype on humans, they see a major potential impact of their discovery on both undetected diabetics and those who dread the continual monitoring the condition require …

    • Lilly says arthritis pill effective in mid-stage study Reuters - Thu, Jun 13, 2013

      (Reuters) - Eli Lilly and Co and Incyte Corp said their experimental drug was effective in reducing painful symptoms associated with rheumatoid arthritis after 52 weeks … More »Lilly says arthritis pill effective in mid-stage study

      (Reuters) - Eli Lilly and Co and Incyte Corp said their experimental drug was effective in reducing painful symptoms associated with rheumatoid arthritis after 52 weeks of treatment. The drug, baricitinib, is part of a new family of medicines called JAK inhibitors that block enzymes believed to be involved in the inflammatory …

    • Drugmakers to cooperate in safety review of diabetes drugs Bill Berkrot - Reuters - Wed, Jun 12, 2013

      By Bill Berkrot NEW YORK (Reuters) - Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between … More »Drugmakers to cooperate in safety review of diabetes drugs

      By Bill Berkrot NEW YORK (Reuters) - Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between widely used diabetes medicines and pancreatic cancer and other safety problems. The American Diabetes Association (ADA) this week called for a new evaluation …

    • Amgen says drug slowed ovarian cancer in trial Reuters - Wed, Jun 12, 2013

      (Reuters) - Amgen Inc's trebananib drug for ovarian cancer extended the length of time that patients lived without the disease getting worse by about two months, meeting … More »Amgen says drug slowed ovarian cancer in trial

      (Reuters) - Amgen Inc's trebananib drug for ovarian cancer extended the length of time that patients lived without the disease getting worse by about two months, meeting the main goal of a late-stage clinical trial, the company said on Wednesday. The trial is the first of three pivotal-stage studies of the experimental …